239 filings
Page 8 of 12
8-K
f358s8
16 Dec 19
Other Events
7:30am
8-K
4pmvbw90l
9 Dec 19
Sesen Bio Initiates Rolling Submission of BLA for Vicinium to FDA
7:45am
8-K
fkad2daypvfnd skk9q7
4 Dec 19
Sesen Bio Completes Successful CMC Type B pre-BLA Meeting with FDA
4:31pm
8-K
qz7kzng cpn9ze
29 Nov 19
Entry into a Material Definitive Agreement
8:51am
8-K
nhexedvcx i1ias3e
12 Nov 19
Results of Operations and Financial Condition
7:05am
8-K
clsa8qi6 nui4xhf
8 Nov 19
Results of Operations and Financial Condition
5:28pm
8-K
dzjizd1yh13leei
5 Nov 19
Sesen Bio Announces Successful Type C Meeting with FDA for Vicinium
4:51pm
8-K
0r9q83j9cdrxq
29 Oct 19
Sesen Bio Strengthens Strategic and Financial Optionality
4:53pm
8-K
9um9aiux1 h344gjy3s6
10 Sep 19
Other Events
7:00am
8-K
7kkm57js 3irf3
26 Aug 19
Departure of Directors or Certain Officers
4:45pm
8-K
ld0isb
8 Aug 19
Results of Operations and Financial Condition
4:29pm
8-K/A
z35bvhi8qq 3hphqvrm8
7 Aug 19
Results of Operations and Financial Condition
9:34pm
8-K
np54 715ts
7 Aug 19
Financial Statements and Exhibits
7:01am
8-K
jbnmcvi
18 Jul 19
Departure of Directors or Certain Officers
8:33am
8-K
51h6zr8cyfmqk69s09h
25 Jun 19
Departure of Directors or Certain Officers
4:34pm
8-K
30l prtnlqaiu
19 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
p4d0czvd
10 Jun 19
FDA Recommends Accelerated Approval Pathway
9:38am
8-K
6szvjw
13 May 19
Results of Operations and Financial Condition
7:02am
8-K
p40r0cgsrd1x0
30 Apr 19
Other Events
12:00am
8-K
ualzji6wmry9ux
4 Mar 19
Results of Operations and Financial Condition
7:32am